Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/17/15 → 3/17/21 |
Funding
- Quintiles, Inc. (Prot #GA29102)
- Genentech, Inc. (Prot #GA29102)
Prot #GA29102: Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy (Maintenance Of Remission) And Safety Of Etrolizumab Compared With Placebo In Patients With Moderate To Severe Active Ulcerative Colitis Who
- Hanauer, stephen B (PD/PI)
Project: Research project